LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 503, 138-150
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (20YF1438700, 81772746, 81870516, 81930018)
- National Natural Science Foundation of China (20YF1438700, 81772746, 81870516, 81930018)
This publication has 60 references indexed in Scilit:
- Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cellsJournal of Clinical Investigation, 2013
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis InitiationCancer Cell, 2012
- A radiolabeled nonapeptide probe targeting PC‐3 cells and bone metastases of prostate cancer in miceContrast Media & Molecular Imaging, 2012
- The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptorMolecular and Cellular Endocrinology, 2012
- Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic CarcinogenesisCancer Research, 2011
- Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer ProgressionCancer Research, 2010
- Targeting the stromal androgen receptor in primary prostate tumors at earlier stagesProceedings of the National Academy of Sciences, 2008
- The significance of LMO2 expression in the progression of prostate cancerThe Journal of Pathology, 2006
- Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1Proceedings of the National Academy of Sciences, 2006
- Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissuesJournal of Cellular Physiology, 2006